Gillespie, J.A.: Vasodilator drugs in occlusive vascular disease of the legs. Lancet, 2: 995, 1959.
2.
Fastier, F.N. , Speden, R.N., AND Waal, H.: Prolongation of chloral hydrate sleeping time by 5-hydroxytryptamine and by certain other drugs. Brit. J. Pharmacol., 12: 251, 1957.
Yater, W.M., AND Cahill, J.A.: Bilateral gangrene of feet due to ergotamine tartrate used for pruritis of jaundice. J. A. M. A., 106: 1625, 1936.
5.
Necheles, T.F. , Weinstein, I.M., AND Leroy, G.V.: Radioactive sodium chromate for the study of survival of red blood cells. J. Lab. & Clin. Med., 42: 358, 1953.
6.
Price, H.L.: General anesthesia and circulatory homeostasis. Physiol. Rev. , 40: 187, 1960.
7.
Stein, I.D.: An evaluation of vasodilating measures in peripheral arterial insufficiency . Angiology, 7: 432, 1956.
8.
Wertheimer, L., Redisch, W., Hirschhorn , K., AND Steele, J.N.: Patterns of surface temperature response to various agents. Circulation , 11: 110, 1955.
9.
Mitchell, G.A.G.: Cardiovascular Innervation. The Williams & Wilkins Co., Baltimore, 1956.
10.
Anderson, L.H. , AND Wells, J.A.: Attempts to prevent ergot gangrene with heparin and dicoumarol: Vascular effects of ergot by fluorescein technic . Proc. Soc. Exp. Biol. Med., 67: 53, 1948.
11.
Sjostrand, T.: Regulatory mechanisms relating to blood volume. Minnesota Med., 37: 10, 1954.
12.
Freedman, L. : Arlidin—A new vasodilative sympathomimetic drug. Angiology, 6: 52, 1955.
13.
Nickerson, M.: The pharmacology of adrenergic blockade. Pharmacol. Rev., 1: 27, 1949.
14.
Goodwin, J.F. : Vasodilator drugs for peripheral vascular disease . Brit. M. J., 1: 1800, 1960.
15.
Kaindl, F.: Peripheral vasodilation: Methods of evaluation and the correlation with clinical practice. Angiology, 11: 15, 1960.
16.
Richards, R.L. : Prognosis of intermittent claudication. Brit. M. J., 2: 1091, 1957.
